Cash Cash Equivalents - PainChek Ltd (ASX:PCK) - Alpha Spread

PainChek Ltd
ASX:PCK

Watchlist Manager
PainChek Ltd Logo
PainChek Ltd
ASX:PCK
Watchlist
Price: 0.032 AUD 3.23% Market Closed
Market Cap: 52.3m AUD
Have any thoughts about
PainChek Ltd?
Write Note

PainChek Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PainChek Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
M7T
4DX
CGS
PME
MDR

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
PainChek Ltd
ASX:PCK
Cash & Cash Equivalents
AU$3.6m
CAGR 3-Years
-32%
CAGR 5-Years
-5%
CAGR 10-Years
38%
Mach7 Technologies Ltd
ASX:M7T
Cash & Cash Equivalents
AU$26.2m
CAGR 3-Years
13%
CAGR 5-Years
63%
CAGR 10-Years
47%
4DMedical Ltd
ASX:4DX
Cash & Cash Equivalents
AU$30.6m
CAGR 3-Years
-28%
CAGR 5-Years
58%
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Cash & Cash Equivalents
$30.1m
CAGR 3-Years
8%
CAGR 5-Years
56%
CAGR 10-Years
41%
Pro Medicus Ltd
ASX:PME
Cash & Cash Equivalents
AU$60.1m
CAGR 3-Years
13%
CAGR 5-Years
20%
CAGR 10-Years
16%
Medadvisor Ltd
ASX:MDR
Cash & Cash Equivalents
AU$15.6m
CAGR 3-Years
30%
CAGR 5-Years
29%
CAGR 10-Years
45%

See Also

What is PainChek Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
3.6m AUD

Based on the financial report for Jun 30, 2024, PainChek Ltd's Cash & Cash Equivalents amounts to 3.6m AUD.

What is PainChek Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
38%

Over the last year, the Cash & Cash Equivalents growth was 42%. The average annual Cash & Cash Equivalents growth rates for PainChek Ltd have been -32% over the past three years , -5% over the past five years , and 38% over the past ten years .

Back to Top